AOL
MAIL
- You might also like:
- AOL Jobs,
- AOL Real Estate
- and More

Ticker

Advertisement Find a Broker - Visit the DailyFinance Broker Center

DJIA	12,454.83	-74.92	-0.60%
NASDAQ	2,837.53	-1.85	-0.07%
S&P 500	1,317.82	-2.86	-0.22%

Recent Quotes Watchlist My Portfolios

Add

$44.05 $1.38 (3.23%)

REAL-TIME: Last trade at 4:00 PM EDT on 05/25/12

United Therapeutics Corp

NASDAQ:UTHR

+ Add to Portfolio
+ Add to Alerts

Related Resources

United Therapeutics has a conference call hosted by JP Morgan

5/23/2012 by Theflyonthewall.com

UTHR Beats on Lower Expenses - Analyst Blog

4/30/2012 by Zacks Investment Research

UTHR Beats on Lower Expenses

4/30/2012 by Zacks Equity Research Analyst Blog

Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis And United Therapeutics

4/28/2012 by Biocompare

UPDATE - Canaccord Genuity Downgraded United Therapeutics (UTHR) to Hold; Sidelined on Uncertainty

4/27/2012 by StreetInsider.com

Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics

4/27/2012 by PR Newswire

Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics - Press Releases

4/27/2012 by Zacks Investment Research

United Therapeutics downgraded to Hold from Buy at Canaccord

4/27/2012 by Theflyonthewall.com

United Therapeutics' CEO Discusses Q1 2012 Results - Earnings Call Transcript

4/26/2012 by Seeking Alpha

United Therapeutics reports strong quarter

4/26/2012 by Washington Business Journal - Washington DC

United Therapeutics (UTHR) Tops Q1 EPS Views; Reaffirms Outlook

4/26/2012 by StreetInsider.com

United Therapeutics backs 2012 revenue view of down 5%-up 5%

4/26/2012 by Theflyonthewall.com

United Therap.:backs 2012 revenue guidance for Remodulin, Tyvaso and Adcirca

4/26/2012 by Theflyonthewall.com

United Therapeutics reports Q1 diluted EPS $1.29, consensus 93c

4/26/2012 by Theflyonthewall.com

United Therapeutics Corporation Reports First Quarter 2012 Financial Results

4/26/2012 by StockWatch

United Therapeutics Corporation Reports First Quarter 2012 Financial Results

4/26/2012 by PR Newswire

United Therapeutics Corporation To Announce First Quarter 2012 Financial Results Before Market Open On Thursday, April 26, 2012

4/19/2012 by PR Newswire

Leerink Swann Downgrades United Therapeutics Corp. (UTHR) to Market Perform; Generic Risk

4/12/2012 by StreetInsider.com

United Therapeutics downgraded to Market Perform from Outperform at Leerink

4/12/2012 by Theflyonthewall.com

Neutral on United Therapeutics

3/30/2012 by Zacks Equity Research Analyst Blog

Neutral on United Therapeutics - Analyst Blog

3/30/2012 by Zacks Investment Research

Canaccord Genuity Starts United Therapeutics Corp. (UTHR) at Buy

3/26/2012 by StreetInsider.com

United Therapeutics shares undervalued, says Argus

3/20/2012 by Theflyonthewall.com

UTHR Files Suit vs. Sandoz - Analyst Blog

3/16/2012 by Zacks Investment Research

UTHR Files Suit vs. Sandoz

3/16/2012 by Zacks Equity Research Analyst Blog

United Therapeutics Suing Sandoz

3/16/2012 by Drug Discovery & Development

United Therapeutics sues to halt generic competition

3/15/2012 by Washington Business Journal - Washington DC

United Therapeutics sues over generic Remodulin

3/15/2012 by Product Design and Development

United Therapeutics files lawsuit against Sandox for infringement of Remodulin

3/15/2012 by Theflyonthewall.com

United Therapeutics Files Lawsuit Against Sandoz for Infringement of Remodulin Patents

3/15/2012 by PR Newswire

Standpoint Research Starts United Therapeutics Corp. (UTHR) at Buy

3/12/2012 by StreetInsider.com

United Therapeutics initiated with a Buy at Standpoint Research

3/12/2012 by Theflyonthewall.com

Action Date for UTHR Candidate - Analyst Blog

2/24/2012 by Zacks Investment Research

Action Date for UTHR Candidate

2/24/2012 by Zacks Equity Research Analyst Blog

Oral Treprostinil New Drug Application Accepted by FDA for Review

2/21/2012 by PR Newswire

Auriga Maintains a 'Hold' on United Therapeutics (UTHR); Q4 Review

2/15/2012 by StreetInsider.com

UTHR Misses Expectations - Analyst Blog

2/15/2012 by NASDAQ

UTHR Misses Expectations - Analyst Blog

2/15/2012 by Zacks Investment Research

United Therapeutics 4Q profit up, but falls short

2/14/2012 by Bioscience Technology

United Therapeutics' CEO Discusses Q4 2011 Results - Earnings Call Transcript

2/14/2012 by Seeking Alpha

See More Articles...

Get the latest UTHR stock information on the web. Get the latest stock quote and more - DailyFinance is your source for United Therapeutics Corp stock price.

BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
Analyst Recommendations provided by Midnight Trader, Inc. Company Conference Calls provided by Wall Street Horizon.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions.

Notices & Terms: Confirm all data with your broker before trading.

Questions or Comments? Please give feedback here.

© 2012 AOL Inc. All Rights Reserved.

AOL@Money © 2012 AOL Inc. All Rights Reserved.

WEB103 / 46.8771 ms